
Ocean Biomedical, Inc.
NASDAQ:OCEA
0.02 (USD) • At close April 23, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Ocean Biomedical, Inc. |
Symbool | OCEA |
Munteenheid | USD |
Prijs | 0.021 |
Beurswaarde | 3,403,226 |
Dividendpercentage | 0% |
52-weken bereik | 0.005 - 2.09 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Elizabeth Ng M.B.A. |
Website | http://www.oceanbiomedical.com |
An error occurred while fetching data.
Over Ocean Biomedical, Inc.
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)